Medicaments containing vardenafil hydrochloride trihydrate

US8841446B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Peter Serno · Bensberg, DE
• Alfons Grunenberg · Wuppertal, DE
• Andreas Ohm · Neuss, DE
• Rainer Bellinghausen · Neunburg vorm Wald, DE
• Elmer Vollers · Leverkusen, DE
• Jan-Olav Henck · Willich, DE

Key dates

• Filing date: Sep 24, 2012
• Grant date: Sep 23, 2014
• Expiry date: Sep 24, 2032

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a method for producing medicaments that contain vardenafil hydrochloride, essentially as trihydrate in solid form, and to medicaments that can be obtained according to this method.